日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteome changes associated with effect of high dose single-fractionation radiation on lung adenocarcinoma cell lines.

高剂量单次分割放射治疗对肺腺癌细胞系的影响及其相关的蛋白质组变化

Leis Elina, Modhukur Vijayachitra, Lust Helen, Vardja Markus, Saarma Merilin, Ilves Ivar, Pütsepp Margaret, Kopanchuk Sergei, Jaal Jana, Lavogina Darja

Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon

重新审视基于Resazurin的细胞活力传感:拓宽应用范围

Darja Lavogina, Helen Lust, Maris-Johanna Tahk, Tõnis Laasfeld, Hans Vellama, Naila Nasirova, Markus Vardja, Kattri-Liis Eskla, Andres Salumets, Ago Rinken, Jana Jaal

Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets

胶质母细胞瘤细胞系的活力指纹:有丝分裂、增殖和表观遗传靶点的作用

Darja Lavogina, Tõnis Laasfeld, Markus Vardja, Helen Lust, Jana Jaal

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients

血管数量及CD133和ICAM-1血管表达对胶质母细胞瘤患者生存的影响

Ave Minajeva, Marju Kase, Mikk Saretok, Aidi Adamson-Raieste, Sandra Kase, Kristi Niinepuu, Markus Vardja, Toomas Asser, Jana Jaal

VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment

多形性胶质母细胞瘤中的 VEGFR-2 表达依赖于炎症性肿瘤微环境

Jana Jaal, Marju Kase, Ave Minajeva, Mikk Saretok, Aidi Adamson, Jelizaveta Junninen, Tõnis Metsaots, Tõnu Jõgi, Madis Joonsalu, Markus Vardja, Toomas Asser

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

CD133阳性干细胞比例对多形性胶质母细胞瘤患者生存率的影响

Kase, Marju; Minajeva, Ave; Niinepuu, Kristi; Kase, Sandra; Vardja, Markus; Asser, Toomas; Jaal, Jana